Machine Learning Frontier Scientist - AI Drug Discovery

SystImmune is a leading and well-funded clinical-stage biopharmaceutical company located in Redmond, WA and Princeton, NJ.

It specializes in developing innovative cancer treatments using its established drug development platforms, focusing on bi-specific, multi-specific antibodies, and antibody-drug conjugates (ADCs).

SystImmune has multiple assets in various stages of clinical trials for solid tumor and hematologic indications.

Alongside ongoing clinical trials, SystImmune has a robust preclinical pipeline of potential cancer therapeutics in the discovery or IND-enabling stages, representing cutting-edge biologics development.

We offer an opportunity for you to learn and grow while making significant contributions to the company’s success.

With a growing pipeline and multiple clinical programs in solid tumors and hematologic malignancies, we are expanding our AI and computational discovery team to identify novel drug targets and design next-generation therapeutics.

We are seeking a Machine Learning Frontier Scientist with a proven track record applying AI to drug development, specifically in areas like target discovery, antibody or ADC engineering, and cancer immunotherapy.

This is not a data management role.

The ideal candidate will bring domain-specific expertise in oncology, immunology, or protein therapeutics and be comfortable operating at the frontier of ML applications in therapeutic design.

Responsibilities Drug Target Discovery :

• Develop and apply ML / AI methods to identify and prioritize novel drug targets, including T cell engagers, ADCs, and multispecific antibodies.

Therapeutic Design :

Model Development :

Data Mining for Oncology :

Cross-functional Collaboration :

Scientific Feedback Loop :

This role is not a fit for :

Compensation and Benefits :

SystImmune offers a comprehensive benefits package including :

We welcome diverse talent and encourage all qualified applicants to apply.   Powered by JazzHR